Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) had its price target increased by equities researchers at Citigroup Inc. from $21.00 to $25.00.Citigroup Inc. currently has a rating of Buy on the stock. A number of other analysts have spoken on the company in recent days, and Lexicon Pharmaceuticals Inc. has earned a consensus one-year price target of $21.90, higher than the opening price of $17.60, a difference of 11.80 percent. Lexicon Pharmaceuticals Inc. stock has a 52-week high of $19.19.
U.S. stocks finished higher on Monday as investor fears for an interest rate hike subsided after Federal Reserve Board Governor Lael Brainard urged caution about removing monetary stimulus too quickly.
The Dow Jones Industrial Average DJIA, +1.32% surged 239.62 points, or 1.3%, to close at 18,325.07, after jumping as high as 273 points.
The S&P 500 SPX, +1.47% rose 31.23 points, or 1.5%, to finish at 2,159.04, with all sectors closing in positive territory.
Meanwhile, the Nasdaq Composite Index COMP, +1.68% finished up 85.98 points, or 1.7%, at 5,211.89, propelled by a rally in biotechnology shares
Share prices sometimes get a bounce to the upside when analysts inititate coverage.
Shares of Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) opened at $17.60 yesterday and traded in a range between, $17.50 and $18.83, and last traded at $18.56, which represents a change of $ 0.71 over the previous closing price.
Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) now has a market cap of 1.93B
The stocks average daily volume is 841,894 shares out of a total float 46,145,000 of and some 2,194,281 shares traded hands yesterday, 43 percent higher than normal. Significant increases in trading volume and price appreciation together could signal heavy volume accumulation by institutional investors.
While increased trading for short periods will not mean much will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.
Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.
These instituitional investors have teams of analysts researching thousands of stocks, so it is good confirmation to see them taking a postion in a stock you’re considering.
By identifying trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.
With that in mind Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) now has a 50-day MA is $15.62 and 200-day MA is $13.84, and it has traded in a 52-week range between $7.65 – 19.19 and today’s last price is -0.03 percent off the 52 week high of $19.19.
Indeed, earnings growth is among the most important things to look in regards to stock investing and, accordingly, investors seek companies who have been successful at growing their earnings by at least 25 percent over a 3 year period.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of BNB Daily News. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.